Dual ACE and Neutral Endopeptidase Inhibitors: Novel Therapy for Patients with Cardiovascular Disorders

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.20, 2003-01, pp. : 2185-2202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined neutral endopeptidase inhibitors

By Cuculi Florim Erne Paul

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 457-463

Informa Healthcare

Access to resources Recommend Favorite

Neutral Endopeptidase Inhibitors and the Pulmonary Circulation

By Thompson J.S. Morice A.H.

General Pharmacology, Vol. 27, Iss. 4, 1996-06 ,pp. : 581-585

Elsevier

Access to resources Recommend Favorite

Cardiovascular Risk in Patients with Early Renal Insufficiency: Implications for the Use of ACE Inhibitors

By Mann J.F.E.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 3, 2002-01 ,pp. : 157-162

Adis International

Access to resources Recommend Favorite

Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin

By Pham I. Gonzalez W. Doucet J. Fournie-Zaluski M.-C. Roques B.P. Michel J.-B.

European Journal of Pharmacology, Vol. 296, Iss. 3, 1996-02 ,pp. : 267-276

Elsevier

Access to resources Recommend Favorite

Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders

Current Pharmaceutical Design, Vol. 18, Iss. 30, 2012-10 ,pp. : 4725-4746

Bentham Science Publishers

Access to resources Recommend Favorite